A microbial pathogen detection platform
AMOUNT AWARDED: $50,000
ABOUT KONRY LAB:
Konry Lab develops rapid, low-cost, highly accurate, and readily available point of care (POCT) testing solutions for microbial pathogen detection.
ABOUT THIS RESEARCH
The worldwide shortage of SARS-CoV-2 reagents has been a significant barrier to an ineffective testing response to the pandemic. Many regional laboratories lack instrumentation, space, or staff proficient in RT-PCR testing. Prolonged intervals for Covid-19 assay results, which sometimes exceeds 48 hours, diminishes the value of testing. Community clinics, small and medium-sized hospitals, transportation venues, industrial sites, educational institutions, employers, and other essential sites require rapid, low cost, highly accurate, and readily available testing solutions.
Dr. Tania Konry is an Inventor of the NDX-C19 technology. A prolific scientist, Dr. Konry, came to Northeastern University from successful terms at Harvard Medical School and Tufts University. She is a talented biomedical researcher with an entrepreneurial spirit.
Dr. Howard Robin is the Chief Medical Officer of NeorahDX. A board-certified pathologist, Dr. Robin has directed, founded, consulted, bought, and sold commercial labs and led large hospital labs. He has consulted with biotechnology companies and university faculty to bring new molecular technologies to the diagnostic marketplace.